Real-world Study on Fenestrated Stent for Thoracic Aortic Dissection

Exclusion Criteria

• •1. Definitive diagnosis of aortic-related connective tissue disorders (e.g., Marfan syndrome);
• •2. Subjects with infectious aortic dissection;
• •3. Documented allergy to nitinol alloys, contrast agents, or related materials;
• •4. Severe hepatic/renal dysfunction (ALT or AST \>2.5×ULN, serum creatinine \>2×ULN);
• •5. Uncontrolled severe infections (e.g., bacteremia or septicemia);
• •6. History of active bleeding, coagulopathy, or refusal of blood transfusion;
• •7. Malignancy with life expectancy \<1 year;
• •8. Pregnancy, lactation, or planned pregnancy during the trial;
• •9. Concurrent participation in other drug/device trials without completing primary endpoints;
• •10. Poor compliance with anticipated inability to complete follow-up;
• •11. Other investigator-determined contraindications for endovascular therapy (e.g., unsuitable vascular access, non-cooperation).